Express Scripts Holding Co. (ESRX)

77.08
NASDAQ : Health Services
Prev Close 76.80
Day Low/High 76.59 / 77.47
52 Wk Low/High 55.80 / 85.07
Avg Volume 5.01M
Exchange NASDAQ
Shares Outstanding 561.72M
Market Cap 43.14B
EPS 7.80
P/E Ratio 9.67
Div & Yield N.A. (N.A)

Latest News

President Trump Unveils Plan to Lower Drug Prices, Drug Companies Spared

President Trump Unveils Plan to Lower Drug Prices, Drug Companies Spared

President Trump and HHS Secretary Alan Azer rolled out a plan to lower out of pocket costs for consumers when it comes to drug prices. Now comes the hard part.

A Surprise Reaction to Nvidia's Earnings Offer Up One Important Investing Lesson

A Surprise Reaction to Nvidia's Earnings Offer Up One Important Investing Lesson

It has been yet another long week on Wall Street. On Friday, investors are greeted with a mild Nvidia earnings related selloff. Be on the lookout for valuation-based tech stock downgrades in the week ahead.

What to Expect From Trump's Speech on Drug Prices on Friday

What to Expect From Trump's Speech on Drug Prices on Friday

Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.

Walmart Will Limit Length of Opioid Prescriptions for First-Time Patients

Walmart Will Limit Length of Opioid Prescriptions for First-Time Patients

Walmart has elected to follow the Centers for Disease Control and Prevention guidelines for first time opioid patients, limiting prescriptions to no longer than a seven day supply.

The Best Thing I Heard From Berkshire's Annual Meeting Didn't Come From Buffett

The Best Thing I Heard From Berkshire's Annual Meeting Didn't Come From Buffett

It was Warren Buffett weekend as the famed investor held court with Berkshire Hathaway investors. Here are several observations for investors.

Inside Rx, A Prescription Savings Program From Express Scripts, Expands List Of Discounted Brand-Name Medications

Added medications offer discounted treatment options for infection, migraine, overactive bladder, attention deficit, seizure and thyroid disorders; expands the program's offerings for heart disease and depression

We Are Never Going Back to Easy Markets: Market Recon

We Are Never Going Back to Easy Markets: Market Recon

Consistency in discipline will make the difference.

The Future of Healthcare Will Have You in Control for a Change: Cigna CEO

The Future of Healthcare Will Have You in Control for a Change: Cigna CEO

Cigna CEO David Cordani is game on in trying to shape the future of healthcare. He talks with TheStreet on where he thinks things are headed.

Cigna CEO: Here's What the Future of Healthcare Looks Like

Cigna CEO: Here's What the Future of Healthcare Looks Like

Cigna CEO David Cordani isn't ready to declare the future of healthcare will mean people go to retail stores to get all problems addressed.

Apple Earnings Could Spook Investors and Send Stocks Plunging to February's Lows

Apple Earnings Could Spook Investors and Send Stocks Plunging to February's Lows

Apple's earnings after the closing bell on Tuesday could set the tone for a meandering stock market. If the tech giant doesn't deliver in a big way, notably with its cash allocation plans, the broader market could easily tank.

Cigna CEO: So Far So Good With Trump Administration on Express Scripts Deal

Cigna CEO: So Far So Good With Trump Administration on Express Scripts Deal

Cigna CEO David Cordani talks to TheStreet on the progress of getting company's big deal for Express Scripts passed by regulators.

Cigna CEO Is Still Bullish on Completing $52 Billion Express Scripts Deal

Cigna CEO Is Still Bullish on Completing $52 Billion Express Scripts Deal

Cigna CEO David Cordani discusses the progress on closing the company's big deal for PBM Express Scripts.

"Knowing But Not Doing: The State Of Rx Adherence In America Report" Finds Big Difference In What Americans Know And Do When It Comes To Their Chronic Medications

Medication Reminders from Spouses are Not Appreciated While Technology Assistance Is

Sohn Investing 2018: An Insider's Recap

Sohn Investing 2018: An Insider's Recap

Doubleline's Gundlach Launches Facebook Short Campaign, Greenlight's Einhorn believes Assured Guarantee has massive losses "baked in" while Bill Ackman Protégé Scott Ferguson eyes a break up of Britain's WhitBread plc.

Here's What to Watch as UnitedHealth Reports Earnings on Tuesday

Here's What to Watch as UnitedHealth Reports Earnings on Tuesday

The company's underwriting margins and traditional health insurance business are key areas to watch, according to BMO Capital Markets' Matthew Borsch.

Here's What a Possible Walmart/Humana Deal Could Mean for Your Retirement

Here's What a Possible Walmart/Humana Deal Could Mean for Your Retirement

Paying for healthcare costs could be among your biggest concerns after retiring. Here's how the possible tie-in might change the way you access care.

See How Express Scripts Holding Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that Express Scripts Holding Co is the #85 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

Second Quarter Predictions

Second Quarter Predictions

Better-than-expected earnings will help soothe market jitters in the second quarter.

Why Express Scripts Stock Could Improve From Here

Why Express Scripts Stock Could Improve From Here

A bullish divergence suggests a possible recovery in the near term.

Video: Jim Cramer on What's Next for Cigna and Express Scripts

Video: Jim Cramer on What's Next for Cigna and Express Scripts

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer isn't expecting much action for shares of Cigna while it awaits its acquisition of Express Scripts to close.

Cigna and Express Scripts: Cramer's Top Takeaways

Cigna and Express Scripts: Cramer's Top Takeaways

David Cordani, president and CEO of health insurance provider Cigna, tells Jim Cramer about the deal for Express Scripts.

Don't Turn Your Back on This Market: Cramer's 'Mad Money' Recap (Monday 3/19/18)

Don't Turn Your Back on This Market: Cramer's 'Mad Money' Recap (Monday 3/19/18)

This market remains elevated, says Jim Cramer. It's perfectly reasonable to have some selling, but remember: Nobody makes money by panicking.

TheStreet Quant Rating: B (Buy)